A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801-Reference-Cited by-同舟云学术

A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801

Published:2018-06-28 Issue:11 Volume:103 Page:1915-1924
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Carpenter Paul A.,Logan Brent R.,Lee Stephanie J.,Weisdorf Daniel J.,Johnston Laura,Costa Luciano J.,Kitko Carrie L.,Bolaños-Meade Javier,Sarantopoulos Stefanie,Alousi Amin M.,Abhyankar Sunil,Waller Edmund K.,Mendizabal Adam,Zhu Jiaxi,O’Brien Kelly A.,Lazaryan Aleksandr,Wu Juan,Nemecek Eneida R.,Pavletic Steven Z.,Cutler Corey S.,Horowitz Mary M.,Arora Mukta

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repeated Infusions of Bone-Marrow-Derived Mesenchymal Stem Cells over 8 Weeks for Steroid-Refractory Chronic Graft-versus-Host Disease: A Prospective, Phase I/II Clinical Study;International Journal of Molecular Sciences;2024-06-19

2. Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study;Bone Marrow Transplantation;2024-05-02

3. Dynamic forecasting module for chronic graft-versus-host disease progression based on a disease-specific subpopulation of B cells;2024-04-22

4. A Novel JAK1 Inhibitor SHR0302 Combined With Prednisone for First-Line Treatment of Chronic Graft-Versus-Host Disease: A Phase I Clinical Trial;Cell Transplantation;2024-01

5. Chronic Graft-Versus-Host Disease;The EBMT Handbook;2024